APA (7th ed.) Citation

MI, S., K, W., F, S., B, R., G, L., S, K., . . . MC, B. (2022). AAV-mediated gene transfer of a checkpoint inhibitor in combination with HER2-targeted CAR-NK cells as experimental therapy for glioblastoma. Oncoimmunology, 11(1), 2127508. https://doi.org/10.1080/2162402X.2022.2127508

Chicago Style (17th ed.) Citation

MI, Strecker, et al. "AAV-mediated Gene Transfer of a Checkpoint Inhibitor in Combination with HER2-targeted CAR-NK Cells as Experimental Therapy for Glioblastoma." Oncoimmunology 11, no. 1 (2022): 2127508. https://doi.org/10.1080/2162402X.2022.2127508.

MLA (9th ed.) Citation

MI, Strecker, et al. "AAV-mediated Gene Transfer of a Checkpoint Inhibitor in Combination with HER2-targeted CAR-NK Cells as Experimental Therapy for Glioblastoma." Oncoimmunology, vol. 11, no. 1, 2022, p. 2127508, https://doi.org/10.1080/2162402X.2022.2127508.